[Microbiocenosis-regulating therapy of inflammatory pathology of the oropharynx].
A V GurovM A YushkinaA V MuzhichkovaPublished in: Vestnik otorinolaringologii (2021)
Inflammatory pathology of the oropharynx, which does not lose its relevance, is a problem that is of interest to doctors of various specialties. As one of the main causes of inflammatory diseases of the pharynx, the influence of microorganisms, primarily viruses, on the mucous membrane of the upper respiratory tract is indicated. The authors of the article emphasize the importance of preserving the indigenous microbiota, which provides a barrier function and prevents the adhesion and colonization of pathogenic microorganisms. In this regard, the most effective and safe is local microbiocenosis-regulatory therapy using lysozyme, a natural peptide that has antiseptic, anti-inflammatory and immunoregulatory effects. As such a drug, the authors recommend the combined drug Lorolizin, which can be used in the treatment of acute pharyngitis, acute tonsillitis, and adenoiditis.
Keyphrases
- respiratory tract
- liver failure
- drug induced
- oxidative stress
- anti inflammatory
- respiratory failure
- aortic dissection
- stem cells
- transcription factor
- emergency department
- hepatitis b virus
- mouse model
- biofilm formation
- combination therapy
- replacement therapy
- escherichia coli
- cell therapy
- staphylococcus aureus
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- mechanical ventilation
- cell adhesion